HDACi combination therapy with IDO1i remodels the tumor microenvironment and boosts antitumor efficacy in colorectal cancer with microsatellite stability

Rongpu Liang,Dongbing Ding,Yiquan Li,Tianyun Lan,Svetlana Ryabtseva,Shengxin Huang,Jiannan Ren,He Huang,Bo Wei

DOI: https://doi.org/10.1186/s12951-024-02936-0

IF: 10.2

2024-12-18

Journal of Nanobiotechnology

Abstract:Immunotherapy for colorectal cancer (CRC) with microsatellite stability (MSS) and mismatch repair proficiency (pMMR) has shown limited success in clinical trials. The combination of immunomodulators and immune checkpoint inhibitors (ICIs) is a potential strategy for treating CRC.

biotechnology & applied microbiology,nanoscience & nanotechnology